Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
US6949571 | EISAI INC | 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
Jun, 2023
(2 months from now) | |
US8772497 | EISAI INC | Method for producing 1, 2-dihydropyridine-2-one compound |
Jul, 2026
(3 years from now) |
Market Authorisation Date: 29 April, 2016
Treatment: Treatment of primary generalized tonic-clonic seizures as adjunctive therapy in patients with epilepsy 12 years of age and older; Treatment of partial-onset seizures with or without secondarily genera...
Dosage: SUSPENSION;ORAL
12
Japan
8
China
6
Israel
6
United States
6
European Union
5
Korea, Republic of
4
Australia
3
Hong Kong
3
Norway
3
Taiwan, Province of China
3
Canada
2
South Africa
2
Denmark
2
Austria
2
Mexico
2
Slovenia
2
Russia
2
Hungary
2
Brazil
2
Portugal
2
Cyprus
2
Spain
2
Poland
2
New Zealand
1
Belgium
1
Jordan
1
Germany
1
Croatia
1
Malaysia
1
Netherlands
1
United Kingdom
1
RS
1
Luxembourg
1
ME
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic